Tamura T, Numata T, Yanai H, Nakamura R, et al. Atezolizumab for EGFR-mutated Non-small Cell Lung Cancer Patients: An Observation Study in Ibaraki Group (ATTENTION-IBARAKI). Anticancer Res 2023;43:4583-4591.
PMID: 37772562